Surgalign Holdings, Inc.
NASDAQ
Recommendation
Prev Close
--
Volume
--
Avg Vol (90D)
--
Market Cap
--
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
| 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 110.60% | -297.75% | -72.87% | -21,166.67% | 100.06% |
| Total Depreciation and Amortization | 10.64% | -18.30% | -10.68% | 9.96% | -9.79% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -161.12% | 1,159.55% | 69.18% | 21.85% | -125.52% |
| Change in Net Operating Assets | -12.41% | 386.25% | -422.02% | 105.14% | 1.46% |
| Cash from Operations | -42.73% | 52.75% | -0.81% | 30.66% | -87.98% |
| Capital Expenditure | 18.48% | 26.21% | -21.60% | -40.60% | 51.29% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 72.00% | 24.70% | -61.17% | -27.16% | 47.06% |
| Cash from Investing | 1,013.05% | 26.10% | -23.77% | -39.79% | 82.67% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.99% | -- | -100.00% | -98.95% | 4,256.02% |
| Repurchase of Common Stock | -150.00% | -14.29% | 86.27% | -920.00% | 86.84% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | -- |
| Cash from Financing | -100.17% | 155,628.57% | -105.19% | -99.01% | 3,597.29% |
| Foreign Exchange rate Adjustments | -23.00% | -291.39% | 165.11% | -241.41% | -53.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 150.41% | 115.81% | -1.08% | -131.97% | 61.28% |